IMIPENEM AND CILASTATIN (imipenem and cilastatin) by R-Pharm US is cilastatin. Approved for the following serious infections caused by designated susceptible bacteria: • lower respiratory tract infections, lower respiratory tract infections caused by susceptible strains of staphylococcus aureus (penicillinase-producing isolates), acinetobacter species and 37 more indications. First approved in 2019.
Drug data last refreshed 19h ago
cilastatin. Imipenem is a penem antibacterial drug [see Clinical Pharmacology (12.4)] . Cilastatin is a renal dehydropeptidase inhibitor that limits the renal metabolism of imipenem.
Penem Antibacterial
Worked on IMIPENEM AND CILASTATIN at R-Pharm US? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Intrapulmonary Pharmacokinetics of XNW4107, Imipenem and Cilastatin in Healthy Subjects